Works matching IS 00282685 AND DT 2024 AND VI 71 AND IP 5

Results: 10

Albumin bound-paclitaxel combined with anlotinib and immunotherapy in the second-line treatment of ES-SCLC: a retrospective cohort study.

Published in:

Neoplasma, 2024, v. 71, n. 5, p. 482, doi. 10.4149/neo_2024_240716N299

By:

Xiaobing LI;
De WU;
Jing TANG;
Yuebing WU

Publication type:

Article

Protein level of epithelial membrane protein (EMP) 1, EMP 2, and EMP 3 in carcinoma of unknown primary.

Published in:

Neoplasma, 2024, v. 71, n. 5, p. 473, doi. 10.4149/neo_2024_240701N280

By:

Eunah SHIN;
Ja Seung KOO

Publication type:

Article

Determination of serum vitamin D in patients with renal, bladder, and prostate cancer by ultra-performance liquid chromatography-tandem mass spectrometry.

Published in:

Neoplasma, 2024, v. 71, n. 5, p. 463, doi. 10.4149/neo_2024_240802N325

By:

Zhenghong HUANG;
Wanxin ZHANG;
Kun HUANG;
Jiafu FENG

Publication type:

Article

Correction: Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer.

Published in:

Neoplasma, 2024, v. 71, n. 5, p. 509, doi. 10.4149/neo_2024_231104N572COR

By:

Xixi YING;
Zheng SHI;
Rongjun SHAO;
Guangxian YOU;
Zhengbo SONG

Publication type:

Article

Comparative investigation among fluorescence in situ hybridization, DNA- and RNA-sequencing on detecting MYC, BCL2, and BCL6 rearrangements in high-grade B-cell lymphomas.

Published in:

Neoplasma, 2024, v. 71, n. 5, p. 490, doi. 10.4149/neo_2024_240527N236

By:

Fen ZHANG;
Qian CUI;
Haiwei DU;
Xinze LV;
Ting HOU;
Yu CHEN;
Jie CHEN;
Jian LIU;
Jinhai YAN;
Yanhui LIU

Publication type:

Article

The real-world comparison of non-small cell lung cancer survival outcomes depending on immunotherapy treatment and PD-L1 expression level.

Published in:

Neoplasma, 2024, v. 71, n. 5, p. 498, doi. 10.4149/neo_2024_240625N272

By:

ONDRUŠOVÁ, Martina;
SUCHANSKÝ, Martin;
SVIDOVÁ, Soňa VÁNDOR;
CHOWANIECOVÁ, Gabriela;
MRIŇÁKOVÁ, Bela;
SEKEREŠOVÁ, Monika;
JUSKANIČ, Dominik;
ONDRUŠ, Dalibor;
ŠENITKO, Michal

Publication type:

Article

Exploring the role of eIF3m in prostate cancer: regulation of c-Myc signaling pathway and therapeutic implications.

Published in:

Neoplasma, 2024, v. 71, n. 5, p. 442, doi. 10.4149/neo_2024_240603N242

By:

Dongdong GUO;
Cheng MA;
Jianyi GU;
Xinyu ZHAI;
Xinlin CHEN;
Guanqun JU;
Chuanmin CHU;
Xiangyang ZHAN;
Tao WANG;
Mingyue TAN;
Dongliang XU

Publication type:

Article

Six2 regulates the malignant progression and 5-FU resistance of hepatocellular carcinoma through the PI3K/AKT/mTOR pathway and DNMT1/E-cadherin methylation mechanism.

Published in:

Neoplasma, 2024, v. 71, n. 5, p. 451, doi. 10.4149/neo_2024_240511N214

By:

Jianwang LI;
Xiaozhen CHENG;
Denggao HUANG;
Ronghua CUI

Publication type:

Article

EIF4A3-induced circle RNA_ 0001860 promotes growth, invasion, and immune evasion of gastric cancer cells through the miR-618/HMGA2 axis.

Published in:

Neoplasma, 2024, v. 71, n. 5, p. 428, doi. 10.4149/neo_2024_240502N196

By:

Xiaoyi ZHANG;
Jiaqi LI;
Qian ZHANG

Publication type:

Article

The impact of c-Met inhibition on molecular features and metastatic potential of melanoma cells.

Published in:

Neoplasma, 2024, v. 71, n. 5, p. 417, doi. 10.4149/neo_2024_240523N232

By:

DEMKOVA, Lucia;
MATUSKOVA, Miroslava;
GERCAKOVA, Katarina;
KOZOVSKA, Zuzana;
SMOLKOVA, Bozena;
KUCEROVA, Lucia

Publication type:

Article